Trends in the prescribing of oral agents for the management of type 2 diabetes mellitus in the United States, 1990-2001: does type of insurance influence access to innovation?

about

Anti-infectives and the risk of severe hypoglycemia in users of glipizide or glyburide.Ascertainment of outpatient visits by patients with diabetes: The National Ambulatory Medical Care Survey (NAMCS) and the National Hospital Ambulatory Medical Care Survey (NHAMCS).

P2860

Q34012336-A404B46E-FAB0-4952-89FC-61A6123DC4BF Q35690435-43E0085B-6574-4406-913B-AB40EB7A7C4F

P2860

Trends in the prescribing of oral agents for the management of type 2 diabetes mellitus in the United States, 1990-2001: does type of insurance influence access to innovation?

Item

http://www.wikidata.org/entity/Q40270389

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Trends in the prescribing of o ...... nfluence access to innovation?

@en

type

Item

label

Trends in the prescribing of o ...... nfluence access to innovation?

@en

prefLabel

Trends in the prescribing of o ...... nfluence access to innovation?

@en

P1476

Trends in the prescribing of o ...... nfluence access to innovation?

@en

P2093

David A Sclar

http://www.w3.org/2001/XMLSchema#string

Linda M Robison

http://www.w3.org/2001/XMLSchema#string

Tracy L Skaer

http://www.w3.org/2001/XMLSchema#string

P2860

Metformin

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.

The effects of the alpha-glucosidase inhibitor BAY g 5421 (Acarbose) on meal-stimulated elevations of circulating glucose, insulin, and triglyceride levels in man.

Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM. A placebo-controlled dose-comparison study.

Pharmacologic therapy for type 2 diabetes mellitus.

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus.

Sulfonylureas in NIDDM.

P304

940-953

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0145721706295021

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17102161

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

Trends in the prescribing of oral agents for the management of type 2 diabetes mellitus in the United States, 1990-2001: does type of insurance influence access to innovation?

about

P2860

P2860

Trends in the prescribing of oral agents for the management of type 2 diabetes mellitus in the United States, 1990-2001: does type of insurance influence access to innovation?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921